Association of rs6259 polymorphism with SHBG levels and Poly Cystic Ovary Syndrome in Indian population: a case control study
- 12 Downloads
Polycystic ovary syndrome (PCOS) is the most common endocrinopathy of reproductive-aged women. PCOS reflects a number of possible etiologies but its pathophysiology is still unclear. The principal abnormality of the syndrome is hyperandrogenism (70–80%). The access of androgens to target tissues is regulated by sex hormone-binding globulin (SHBG), a transport protein secreted by liver i.e. specific for androgens. Present study was done to find the association of rs6259 polymorphism with SHBG levels and Poly Cystic Ovary Syndrome in Indian population. Present study was a case control study. 400 subjects were enrolled for the study and serum SHBG levels and D327N polymorphism were measured. The D327N polymorphism (wild-type and variant allele) was detected using PCR-RFLP method (restriction enzyme Bbs-I). PCOS group was found to have significantly lower SHBG levels than healthy controls. There was no significant difference in genotype distribution between PCOS and controls (χ2 = 1.0335, p = 0.59). Significant difference in SHBG levels of PCOS and control group highlights the potential of SHBG as a biomarker for PCOS. However, no significant difference in genotype distribution between PCOS and controls provided an insight that rs6259 polymorphism is not associated with the risk of PCOS and SHBG levels.
KeywordsPCOS SHBG Diagnostic marker Susceptibility marker Polymorphism
Authors acknowledge DST-INSPIRE division and DBT-HRD to support the research work and Centre for Medical biotechnology, MDU, Rohtak, Haryana, India to provide a research platform to carry out research work.
Compliance with ethical standards
Conflict of interest
Authors declare no conflict of interest.
- 7.Alexiou E, Hatziagelaki E, Pergialiotis V et al (2017) Hyperandrogenemia in women with polycystic ovary syndrome: prevalence, characteristics and association with body mass index. Horm Mol Biol Clin Investig 29:105–111Google Scholar
- 11.El Tarhouny SA, Zakaria SS, Abdu-Allah AM et al (2015) Study of sex hormone-binding globulin gene polymorphism and risk of type 2 diabetes mellitus in Egyptian men. West Indian Med J 64:338Google Scholar
- 20.Toljan K, Grgić F, Pavičić Baldani D et al (2016) Sex hormone binding globulin (SHBG) as a marker of clinical disorders. Coll Antropol 40:199–209Google Scholar
- 23.Kim JS, Kang HT, Shim JY (2012) The association between the triglyceride to high-density lipoprotein cholesterol ratio with insulin resistance (HOMA-IR) in the general Korean population: based on the National Health and Nutrition Examination Survey in 2007–2009. Diabetes Res Clin Pract 97:132–138CrossRefGoogle Scholar
- 29.Svartberg J, Schirmer H, Wilsgaard T et al (2014) Single-nucleotide polymorphism, rs1799941 in the sex hormone-binding globulin (SHBG) gene, related to both serum testosterone and SHBG levels and the risk of myocardial infarction, type 2 diabetes, cancer and mortality in men: the Tromsø study. Andrology 2:212–218CrossRefGoogle Scholar
- 33.Vanková M, Prazáková S, Lukásová P et al (2010) Extremely low SHBG level in consequence of Pro156Leu SHBG polymorphism—case reports of two women with polycystic ovary syndrome. Vnitrni Lekarstvi 56:1292–1295Google Scholar